Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.
Status:
Not yet recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, double-blind controlled trial to evaluate the efficacy of
placebo versus chlorpheniramine for the prevention of allergic transfusion reactions.